358 related articles for article (PubMed ID: 9521779)
1. Mutations in either nucleotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites.
Urbatsch IL; Beaudet L; Carrier I; Gros P
Biochemistry; 1998 Mar; 37(13):4592-602. PubMed ID: 9521779
[TBL] [Abstract][Full Text] [Related]
2. Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity.
Julien M; Gros P
Biochemistry; 2000 Apr; 39(15):4559-68. PubMed ID: 10758006
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of conserved carboxylate residues in the nucleotide binding sites of P-glycoprotein.
Urbatsch IL; Julien M; Carrier I; Rousseau ME; Cayrol R; Gros P
Biochemistry; 2000 Nov; 39(46):14138-49. PubMed ID: 11087362
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the nucleotide-binding sites of P-glycoprotein that affect substrate specificity modulate substrate-induced adenosine triphosphatase activity.
Beaudet L; Urbatsch IL; Gros P
Biochemistry; 1998 Jun; 37(25):9073-82. PubMed ID: 9636053
[TBL] [Abstract][Full Text] [Related]
5. Both ATP sites of human P-glycoprotein are essential but not symmetric.
Hrycyna CA; Ramachandra M; Germann UA; Cheng PW; Pastan I; Gottesman MM
Biochemistry; 1999 Oct; 38(42):13887-99. PubMed ID: 10529234
[TBL] [Abstract][Full Text] [Related]
6. Analysis of catalytic carboxylate mutants E552Q and E1197Q suggests asymmetric ATP hydrolysis by the two nucleotide-binding domains of P-glycoprotein.
Carrier I; Julien M; Gros P
Biochemistry; 2003 Nov; 42(44):12875-85. PubMed ID: 14596601
[TBL] [Abstract][Full Text] [Related]
7. Large scale purification of detergent-soluble P-glycoprotein from Pichia pastoris cells and characterization of nucleotide binding properties of wild-type, Walker A, and Walker B mutant proteins.
Lerner-Marmarosh N; Gimi K; Urbatsch IL; Gros P; Senior AE
J Biol Chem; 1999 Dec; 274(49):34711-8. PubMed ID: 10574938
[TBL] [Abstract][Full Text] [Related]
8. Both P-glycoprotein nucleotide-binding sites are catalytically active.
Urbatsch IL; Sankaran B; Bhagat S; Senior AE
J Biol Chem; 1995 Nov; 270(45):26956-61. PubMed ID: 7592942
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification, and characterization of cysteine-free mouse P-glycoprotein.
Tombline G; Urbatsch IL; Virk N; Muharemagic A; White LB; Senior AE
Arch Biochem Biophys; 2006 Jan; 445(1):124-8. PubMed ID: 16343415
[TBL] [Abstract][Full Text] [Related]
10. Function of the ABC signature sequences in the human multidrug resistance protein 1.
Ren XQ; Furukawa T; Haraguchi M; Sumizawa T; Aoki S; Kobayashi M; Akiyama S
Mol Pharmacol; 2004 Jun; 65(6):1536-42. PubMed ID: 15155846
[TBL] [Abstract][Full Text] [Related]
11. Functionally similar vanadate-induced 8-azidoadenosine 5'-[alpha-(32)P]Diphosphate-trapped transition state intermediates of human P-glycoprotin are generated in the absence and presence of ATP hydrolysis.
Sauna ZE; Smith MM; Muller M; Ambudkar SV
J Biol Chem; 2001 Jun; 276(24):21199-208. PubMed ID: 11287418
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site.
Urbatsch IL; Sankaran B; Weber J; Senior AE
J Biol Chem; 1995 Aug; 270(33):19383-90. PubMed ID: 7642618
[TBL] [Abstract][Full Text] [Related]
13. Vanadate-induced trapping of nucleotides by purified maltose transport complex requires ATP hydrolysis.
Sharma S; Davidson AL
J Bacteriol; 2000 Dec; 182(23):6570-6. PubMed ID: 11073897
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of P-glycoprotein ATPase activity by procedures involving trapping of nucleotide in catalytic sites.
Sankaran B; Bhagat S; Senior AE
Arch Biochem Biophys; 1997 May; 341(1):160-9. PubMed ID: 9143365
[TBL] [Abstract][Full Text] [Related]
15. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH
Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of the N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker A is critical for ATP hydrolysis.
Jha S; Karnani N; Dhar SK; Mukhopadhayay K; Shukla S; Saini P; Mukhopadhayay G; Prasad R
Biochemistry; 2003 Sep; 42(36):10822-32. PubMed ID: 12962507
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein catalytic mechanism: studies of the ADP-vanadate inhibited state.
Urbatsch IL; Tyndall GA; Tombline G; Senior AE
J Biol Chem; 2003 Jun; 278(25):23171-9. PubMed ID: 12670938
[TBL] [Abstract][Full Text] [Related]
18. The conserved tyrosine residues 401 and 1044 in ATP sites of human P-glycoprotein are critical for ATP binding and hydrolysis: evidence for a conserved subdomain, the A-loop in the ATP-binding cassette.
Kim IW; Peng XH; Sauna ZE; FitzGerald PC; Xia D; Müller M; Nandigama K; Ambudkar SV
Biochemistry; 2006 Jun; 45(24):7605-16. PubMed ID: 16768456
[TBL] [Abstract][Full Text] [Related]
19. Drug binding and nucleotide hydrolyzability are essential requirements in the vanadate-induced inhibition of the human P-glycoprotein ATPase.
Rao US
Biochemistry; 1998 Oct; 37(42):14981-8. PubMed ID: 9778376
[TBL] [Abstract][Full Text] [Related]
20. Functional reassembly of ATP-dependent xenobiotic transport by the N- and C-terminal domains of RLIP76 and identification of ATP binding sequences.
Awasthi S; Cheng JZ; Singhal SS; Pandya U; Sharma R; Singh SV; Zimniak P; Awasthi YC
Biochemistry; 2001 Apr; 40(13):4159-68. PubMed ID: 11300797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]